Food Allergy Market Reached $3.5 Billion in 2025

ResearchAndMarkets.com has published a new report analyzing the food allergy market. The market size was estimated at approximately $3.5 billion in 2025 across key regions including the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan.

Food allergies represent a growing health concern, influenced by genetic factors and co-occurrence with other atopic conditions like asthma and atopic dermatitis. Epinephrine remains the first-line treatment for anaphylaxis, with antihistamines and corticosteroids serving as adjunctive therapies.

Treatment advancements include approved medications such as omalizumab (XOLAIR) and epinephrine nasal spray (NEFFY). One treatment, PALFORZIA, is set to discontinue commercialization by July 2026. Several new therapies, including an epinephrine sublingual film and various desensitization approaches, are currently in clinical trials.

The report forecasts significant growth for the food allergy market, projecting a market size of approximately $10.5 billion by 2036. This expansion is attributed to increasing prevalence and the development of novel immunotherapies. The market is expected to grow at a compound annual growth rate of approximately 9% from 2026 to 2036.